Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer(Cancer Research UK), Nuala McCabe(Institute of Cancer Research), Christopher J. Lord(Breast Cancer Now), Andrew Tutt(Breast Cancer Now), Damian A. Johnson(Breast Cancer Now), Tobias B. Richardson(Breast Cancer Now), Manuela Santarosa(Breast Cancer Now), Krystyna J. Dillon(GW Pharmaceuticals (United Kingdom)), Ian Hickson(GW Pharmaceuticals (United Kingdom)), Charlotte Knights(GW Pharmaceuticals (United Kingdom)), Niall M.B. Martin(GW Pharmaceuticals (United Kingdom)), Stephen P. Jackson(GW Pharmaceuticals (United Kingdom)), Graeme C.M. Smith(GW Pharmaceuticals (United Kingdom)), Alan Ashworth(Breast Cancer Now)
Cited by 6,654